William Hrushesky to Female
This is a "connection" page, showing publications William Hrushesky has written about Female.
Connection Strength
0.855
-
The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer. BMC Cancer. 2011 May 23; 11:193.
Score: 0.020
-
Sunspot dynamics are reflected in human physiology and pathophysiology. Astrobiology. 2011 Mar; 11(2):93-103.
Score: 0.020
-
Circadian transcription profile of mouse breast cancer under light-dark and dark-dark conditions. Cancer Genomics Proteomics. 2010 Nov-Dec; 7(6):311-22.
Score: 0.019
-
Global breast cancer seasonality. Breast Cancer Res Treat. 2010 Aug; 123(1):233-43.
Score: 0.018
-
Actigraphic assessment of daily sleep-activity pattern abnormalities reflects self-assessed depression and anxiety in outpatients with advanced non-small cell lung cancer. Psychooncology. 2010 Feb; 19(2):180-9.
Score: 0.018
-
Circadian time-dependent tumor suppressor function of period genes. Integr Cancer Ther. 2009 Dec; 8(4):309-16.
Score: 0.018
-
Discovery of candidate genes and pathways that may help explain fertility cycle stage dependent post-resection breast cancer outcome. Breast Cancer Res Treat. 2009 Nov; 118(2):345-59.
Score: 0.018
-
The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. Chronobiol Int. 2009 Oct; 26(7):1323-39.
Score: 0.018
-
Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res Treat. 2009 Sep; 117(2):423-31.
Score: 0.016
-
Seasonal modulation of post-resection breast cancer metastasis. Breast Cancer Res Treat. 2008 Sep; 111(2):219-28.
Score: 0.016
-
Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. J Natl Cancer Inst. 2007 Jul 04; 99(13):1053; author reply 1053-4.
Score: 0.015
-
Enhanced surgery-induced angiogenesis among premenopausal women might partially explain excess breast cancer mortality of blacks compared to whites: an hypothesis. Int J Surg. 2007 Oct; 5(5):300-4.
Score: 0.015
-
Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther. 2006 Aug; 5(8):2023-33.
Score: 0.014
-
Chronotherapy of ovarian cancer: effect on blood variables and serum cytokines. A case report. Clin Ter. 2006 Jul-Aug; 157(4):349-54.
Score: 0.014
-
Developmental abnormalities in multiple proliferative tissues of Apc(Min/+) mice. Int J Exp Pathol. 2006 Jun; 87(3):227-36.
Score: 0.014
-
Screening and breast cancer. N Engl J Med. 2006 Feb 16; 354(7):767-9; author reply 767-9.
Score: 0.014
-
Circadian function in patients with advanced non-small-cell lung cancer. Br J Cancer. 2005 Nov 28; 93(11):1202-8.
Score: 0.014
-
Sun exposure, sexual behavior and uterine cervical human papilloma virus. Int J Biometeorol. 2006 Jan; 50(3):167-73.
Score: 0.013
-
Season, sun, sex, and cervical cancer. Cancer Epidemiol Biomarkers Prev. 2005 Aug; 14(8):1940-7.
Score: 0.013
-
Cancer growth and spread are saltatory and phase-locked to the reproductive cycle through mediators of angiogenesis. Mol Cancer Ther. 2005 Jul; 4(7):1065-75.
Score: 0.013
-
Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res Treat. 2005 May; 91(1):47-60.
Score: 0.013
-
Sex cycle modulates cancer growth. Breast Cancer Res Treat. 2005 May; 91(1):95-102.
Score: 0.013
-
A recent illustration of some essentials of circadian chronotherapy study design. J Clin Oncol. 2004 Jul 15; 22(14):2971-2; author reply 2972.
Score: 0.012
-
Re: Melatonin and breast cancer: a prospective study. J Natl Cancer Inst. 2004 Jun 02; 96(11):888-9.
Score: 0.012
-
Circadian timing in cancer treatment: the biological foundation for an integrative approach. Integr Cancer Ther. 2003 Jun; 2(2):105-11.
Score: 0.011
-
Breast cancer screening: controversies and future directions. Curr Opin Obstet Gynecol. 2003 Feb; 15(1):1-8.
Score: 0.011
-
Fertility cycle influence on surgical breast cancer cure. Breast Cancer Res Treat. 2002 Sep; 75(1):65-72.
Score: 0.011
-
Breast cancer screening for women aged 40-49 years: screening may not be the benign process usually thought. J Natl Cancer Inst. 2001 Oct 17; 93(20):1572.
Score: 0.010
-
Wounding from biopsy and breast-cancer progression. Lancet. 2001 Mar 31; 357(9261):1048.
Score: 0.010
-
Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy. Breast Cancer Res Treat. 2001 Feb; 65(3):217-24.
Score: 0.010
-
Rhythmic menstrual cycle modulation of breast cancer biology. J Surg Oncol. 2000 Jul; 74(3):238-41.
Score: 0.009
-
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia. PLoS One. 2020; 15(6):e0234541.
Score: 0.009
-
End of an era for erythropoiesis-stimulating agents in oncology. Int J Cancer. 2020 05 15; 146(10):2829-2835.
Score: 0.009
-
Circadian coordination of cancer growth and metastatic spread. Int J Cancer. 1999 Oct 29; 83(3):365-73.
Score: 0.009
-
Fertility maintenance and 5-fluorouracil timing within the mammalian fertility cycle. Reprod Toxicol. 1999 Sep-Oct; 13(5):413-20.
Score: 0.009
-
Evidence for an ontogenetic basis for circadian coordination of cancer cell proliferation. J Natl Cancer Inst. 1998 Oct 07; 90(19):1480-4.
Score: 0.008
-
Menstrual timing of breast cancer surgery. Am J Surg. 1998 Mar; 175(3):245-61.
Score: 0.008
-
Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR). Cancer Med. 2017 Jul; 6(7):1541-1551.
Score: 0.008
-
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia. J Oncol Pract. 2017 06; 13(6):e562-e573.
Score: 0.008
-
Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia. Br J Haematol. 2018 01; 180(2):301-304.
Score: 0.007
-
Menstrual cycle timing of breast cancer resection. Recent Results Cancer Res. 1996; 140:27-40.
Score: 0.007
-
Square pegs in round holes. Int J Cancer. 1995 Sep 04; 62(5):651-2.
Score: 0.007
-
Adding Bevacizumab to the Treatment of Patients With Non-Small-Cell Lung Cancer: Caveat Emptor. J Oncol Pract. 2015 Sep; 11(5):363-4.
Score: 0.007
-
Cisplatin-associated anemia: an erythropoietin deficiency syndrome. J Clin Invest. 1995 Apr; 95(4):1650-9.
Score: 0.007
-
Menstrual cycle timing of breast cancer resection: prospective study is overdue. J Natl Cancer Inst. 1995 Jan 18; 87(2):143-4.
Score: 0.006
-
Mammography and the menstrual cycle. Int J Cancer. 1994 Oct 01; 59(1):151.
Score: 0.006
-
Circadian dynamics of tumor necrosis factor alpha (cachectin) lethality. J Exp Med. 1994 Sep 01; 180(3):1059-65.
Score: 0.006
-
Breast cancer and the menstrual cycle. J Surg Oncol. 1993 May; 53(1):1-3.
Score: 0.006
-
Circadian cancer pharmacodynamics. Ann Ist Super Sanita. 1993; 29(4):705-10.
Score: 0.006
-
Reduction of breast cancer relapses with perioperative non-steroidal anti-inflammatory drugs: new findings and a review. Curr Med Chem. 2013; 20(33):4163-76.
Score: 0.006
-
NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup. Breast Cancer Res Treat. 2012 Jul; 134(2):881-8.
Score: 0.005
-
Optimal timing of initial breast cancer surgery. Ann Intern Med. 1992 Feb 01; 116(3):268.
Score: 0.005
-
Diminishment of respiratory sinus arrhythmia foreshadows doxorubicin-induced cardiomyopathy. Circulation. 1991 Aug; 84(2):697-707.
Score: 0.005
-
The multifrequency (circadian, fertility cycle, and season) balance between host and cancer. Ann N Y Acad Sci. 1991; 618:228-56.
Score: 0.005
-
The effect of surgical timing within the fertility cycle on breast cancer outcome. Ann N Y Acad Sci. 1991; 618:277-91.
Score: 0.005
-
Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast. BMC Cancer. 2010 Nov 30; 10:656.
Score: 0.005
-
Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma. J Clin Oncol. 1990 Sep; 8(9):1504-13.
Score: 0.005
-
Health care for US veterans and others. Lancet. 1990 Jul 21; 336(8708):182.
Score: 0.005
-
Cleavage of the retinal pigment epithelium-specific protein RPE65 under oxidative stress. Int J Biol Macromol. 2010 Aug 01; 47(2):104-8.
Score: 0.005
-
Melatonin reprogrammes proteomic profile in light-exposed retina in vivo. Int J Biol Macromol. 2010 Aug 01; 47(2):255-60.
Score: 0.005
-
Menstrual influence on surgical cure of breast cancer. Lancet. 1990 Apr 21; 335(8695):984.
Score: 0.005
-
Determination of the therapeutic index of floxuridine by its circadian infusion pattern. J Natl Cancer Inst. 1990 Mar 07; 82(5):386-93.
Score: 0.005
-
Pharmacodynamics of local heparin infusion in a canine renal allograft model. J Pharmacol Exp Ther. 1990 Feb; 252(2):733-8.
Score: 0.005
-
Cancer chronotherapy: a drug delivery challenge. Prog Clin Biol Res. 1990; 341A:1-10.
Score: 0.005
-
Enhancement of respiratory sinus arrhythmia by moderate exercise. Prog Clin Biol Res. 1990; 341A:283-96.
Score: 0.005
-
Oral temperature rhythmometry and substantial within-day variation in zidovudine levels following steady-state dosing in human immunodeficiency virus (HIV) infection. Prog Clin Biol Res. 1990; 341A:67-76.
Score: 0.005
-
Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer. J Clin Oncol. 1989 Nov; 7(11):1710-9.
Score: 0.004
-
Menstrual influence on surgical cure of breast cancer. Lancet. 1989 Oct 21; 2(8669):949-52.
Score: 0.004
-
Neuroprotective role of erythropoietin by antiapoptosis in the retina. J Neurosci Res. 2009 Aug 01; 87(10):2365-74.
Score: 0.004
-
Menstrual history and breast cancer surgery. Breast Cancer Res Treat. 1989 Jul; 13(3):278.
Score: 0.004
-
Sinusoidal fetal heart rate pattern during breathing is related to the respiratory sinus arrhythmia: a case report. Am J Obstet Gynecol. 1989 Mar; 160(3):690-2.
Score: 0.004
-
Control of a murine plasmacytoma with doxorubicin-cisplatin: dependence on circadian stage of treatment. J Natl Cancer Inst. 1989 Jan 18; 81(2):135-45.
Score: 0.004
-
Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer. BMC Cancer. 2009 Jan 08; 9:7.
Score: 0.004
-
Circadian rhythm and seasonal dependence in the toxicological response of mice to epirubicin. Invest New Drugs. 1988 Dec; 6(4):273-83.
Score: 0.004
-
Natural killer cell activity: age, estrous- and circadian-stage dependence and inverse correlation with metastatic potential. J Natl Cancer Inst. 1988 Oct 05; 80(15):1232-7.
Score: 0.004
-
Splenocyte natural killer cell activity and metastatic potential are inversely dependent on estrous stage. Surgery. 1988 Aug; 104(2):398-403.
Score: 0.004
-
Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer. APMIS. 2008 Jul-Aug; 116(7-8):730-41.
Score: 0.004
-
Estrous influence on surgical cure of a mouse breast cancer. J Exp Med. 1988 Jul 01; 168(1):73-83.
Score: 0.004
-
A four-arm, randomized, multicenter phase II trial of oxaliplatin combined with varying schedules of 5-fluorouracil as first-line therapy in previously untreated advanced colorectal cancer. Clin Colorectal Cancer. 2008 Mar; 7(2):134-9.
Score: 0.004
-
Progressive metastatic renal cell carcinoma controlled by continuous 5-fluoro-2-deoxyuridine infusion. J Urol. 1988 Feb; 139(2):259-62.
Score: 0.004
-
Circadian-based infusional chrono-chemotherapy controls progressive metastatic renal cell carcinoma. Semin Surg Oncol. 1988; 4(2):110-5.
Score: 0.004
-
Methylene blue protects intestinal mucosa from free radical-mediated sublethal radiation damage. Free Radic Biol Med. 1988; 5(4):207-13.
Score: 0.004
-
Racial disparities in breast cancer outcome: insights into host-tumor interactions. Cancer. 2007 Nov 01; 110(9):1880-8.
Score: 0.004
-
High-dose intensity, circadian-timed doxorubicin and cisplatin adjuvant chemotherapy for bladder cancer. Cancer Treat Rep. 1987 Oct; 71(10):915-9.
Score: 0.004
-
Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119). Int J Radiat Oncol Biol Phys. 2007 Jul 01; 68(3):852-7.
Score: 0.004
-
High-dose intensity systemic therapy of metastatic bladder cancer. J Clin Oncol. 1987 Mar; 5(3):450-5.
Score: 0.004
-
Comment to "Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and intact primary tumor" by G V Babiera, R Rao, L Feng, F Meric-Bernstam, H M Kuerer, S E Singletary, K K Hunt, M I Ross, K M Gwyn, B W Feig, F C Ames, G N Horthobagyi. Ann Surg Oncol 2006;13:776-782. Ann Surg Oncol. 2007 Apr; 14(4):1519-20.
Score: 0.004
-
Chemotherapy-induced vomiting: circadian drug timing as a source of predictable within-patient variability. Cancer Treat Rep. 1986 Nov; 70(11):1347-8.
Score: 0.004
-
Allometric scaling law questions the traditional mechanical model for axillary lymph node involvement in breast cancer. J Clin Oncol. 2006 Sep 20; 24(27):4391-6.
Score: 0.004
-
Comment to Anderson WF, Jatoi I, Devesa SS: distinct breast cancer incidence and prognostic patterns in the NCI'S SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137, 2005. Breast Cancer Res Treat. 2006 Jun; 97(3):341-3.
Score: 0.004
-
Cancer chronomics III. Chronomics for cancer, aging, melatonin and experimental therapeutics researchers. J Exp Ther Oncol. 2006; 6(1):73-84.
Score: 0.003
-
Advanced transitional cell bladder cancer: a treatable disease. Semin Surg Oncol. 1986; 2(2):76-89.
Score: 0.003
-
Cisplatin chronotherapy and disulfiram rescue reduce toxicity without interfering with anticancer activity: animal findings and preliminary clinical experiences. Chronobiol Int. 1986; 3(1):55-64.
Score: 0.003
-
Utility of non-invasive instantaneous screening test for drug-induced cardiac damage. J Clin Oncol. 1985 Oct; 3(10):1438-9.
Score: 0.003
-
Comment to Jatoi et al. report. Breast Cancer Res Treat. 2005 Sep; 93(1):1-2.
Score: 0.003
-
Lack of antiemetic effect of high-dose metoclopramide. J Clin Oncol. 1985 Sep; 3(9):1273-6.
Score: 0.003
-
Circadian timing of cancer chemotherapy. Science. 1985 Apr 05; 228(4695):73-5.
Score: 0.003
-
Cisplatin neurotoxicity: failure to demonstrate vitamin B12 inactivation. Cancer Treat Rep. 1985 Apr; 69(4):453-5.
Score: 0.003
-
Modifying intracellular redox balance: an approach to improving therapeutic index. Lancet. 1985 Mar 09; 1(8428):565-7.
Score: 0.003
-
Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer. 2005 Mar; 41(4):508-15.
Score: 0.003
-
Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology. 2005 Jan; 41(1):88-96.
Score: 0.003
-
Recent translational research: computational studies of breast cancer. Breast Cancer Res. 2005; 7(1):37-40.
Score: 0.003
-
Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour. Breast Cancer Res. 2004; 6(6):R689-96.
Score: 0.003
-
24-hour mean pulse. Simple predictor of doxorubicin-induced cardiac damage. Am J Med. 1984 Sep; 77(3):399-406.
Score: 0.003
-
The respiratory sinus arrhythmia: a measure of cardiac age. Science. 1984 Jun 01; 224(4652):1001-4.
Score: 0.003
-
Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients. Breast Cancer Res. 2004; 6(4):R372-4.
Score: 0.003
-
Lack of age-dependent cisplatin nephrotoxicity. Am J Med. 1984 Apr; 76(4):579-84.
Score: 0.003
-
Circadian mesor of recumbent pulse--cost-effective predictor of doxorubicin-induced congestive heart failure. Chronobiol Int. 1984; 1(1):59-66.
Score: 0.003
-
Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screening. J Clin Oncol. 2004 Jan 01; 22(1):102-7.
Score: 0.003
-
The clinical application of chronobiology to oncology. Am J Anat. 1983 Dec; 168(4):519-42.
Score: 0.003
-
Circadian rhythmicity of polyamine urinary excretion. Cancer Res. 1983 Aug; 43(8):3944-7.
Score: 0.003
-
Circadian time dependence of cisplatin urinary kinetics. Clin Pharmacol Ther. 1982 Sep; 32(3):330-9.
Score: 0.003
-
Circadian stage dependence of cis-diamminedichloroplatinum lethal toxicity in rats. Cancer Res. 1982 Mar; 42(3):945-9.
Score: 0.003
-
Cisplatin-incorporated polymeric micelles eliminate nephrotoxicity, while maintaining antitumor activity. Jpn J Cancer Res. 2001 Mar; 92(3):328-36.
Score: 0.002
-
Circadian organization of thymidylate synthase activity in normal tissues: a possible basis for 5-fluorouracil chronotherapeutic advantage. Int J Cancer. 2000 Nov 01; 88(3):479-85.
Score: 0.002
-
Subcutaneous heparin-induced thrombocytopenia. Arch Intern Med. 1978 Oct; 138(10):1489-91.
Score: 0.002
-
Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics. Exp Hematol. 1998 Jun; 26(6):523-33.
Score: 0.002
-
Thrombocytopenia induced by low-dose subcutaneous heparin. Lancet. 1977 Dec 17; 2(8051):1286.
Score: 0.002
-
Current status of the therapy of advanced renal carcinoma. J Surg Oncol. 1977; 9(3):277-88.
Score: 0.002
-
Steroid-responsive interstitial lung disease in patients receiving 2'-deoxy-5-fluorouridine-infusion chemotherapy. A report of three cases. Cancer. 1995 May 15; 75(10):2558-64.
Score: 0.002
-
A murine renal cell carcinoma. J Natl Cancer Inst. 1973 Apr; 50(4):1013-25.
Score: 0.001
-
Carcinogenicity of ethylmethanesulfonate. J Natl Cancer Inst. 1972 Oct; 49(4):1077-83.
Score: 0.001
-
Mizoribine pharmacokinetics and pharmacodynamics in a canine renal allograft model of local immunosuppression. Transplantation. 1992 Jan; 53(1):12-9.
Score: 0.001
-
Circadian rhythm alteration in HIV infected subjects. Prog Clin Biol Res. 1990; 341A:437-49.
Score: 0.001
-
Local immunosuppression with reduced systemic toxicity in a canine renal allograft model. Transplantation. 1989 Dec; 48(6):936-43.
Score: 0.001
-
Feasibility of vascular catheter placement for intrarenal infusion in a canine autotransplant model. Transplant Proc. 1989 Feb; 21(1 Pt 1):1125-6.
Score: 0.001
-
The chronopharmacokinetics of cyclosporine and its metabolites in recipients of pancreas allografts. Transplant Proc. 1988 Apr; 20(2 Suppl 2):471-7.
Score: 0.001
-
[Biological rhythms and tumor markers in man. With special reference to the carcinoembryonic antigen (CEA) and alpha fetoprotein (AFP) in digestive system tumors]. Acta Gastroenterol Belg. 1987 Jan-Feb; 50(1):12-21.
Score: 0.001
-
Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology. 1984 Jul; 34(7):934-8.
Score: 0.001
-
Cisplatin urinary pharmacokinetics and nephrotoxicity: a common circadian mechanism. Cancer Treat Rep. 1982 Nov; 66(11):1933-8.
Score: 0.001
-
Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration. Eur J Cancer Clin Oncol. 1982 May; 18(5):471-7.
Score: 0.001
-
Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing. Cancer Res. 1982 Mar; 42(3):950-5.
Score: 0.001
-
Time-varying effects in mice and rats of several synthetic ACTH preparations. Chronobiologia. 1980 Apr-Jun; 7(2):211-26.
Score: 0.001
-
Synthetic adrenocorticotropin for optimizing murine circadian chronotolerance for adriamycin. Chronobiologia. 1980 Apr-Jun; 7(2):227-44.
Score: 0.001
-
Influence of hormone therapy on rats treated with the carcinogen ethylmethanesulphonate. Res Commun Chem Pathol Pharmacol. 1974 Jan; 7(1):25-30.
Score: 0.000